11690
M. Ortega et al. / Tetrahedron 61 (2005) 11686–11691
ES(C): 191.2 (MC1). Anal. Calcd for C12H18N2: C, 75.74;
H, 9.53; N, 14.72. Found: C, 75.61; H, 9.50; N, 14.73.
4.5.11. N-benzhydrylcyclohexanamine (3l). 1H NMR
(CDCl3): d 1.06–1.94 (m, 11H), 2.36–2.42 (m, 1H), 5.03
(s, 1H), 7.16–7.39 (m, 10H). 13C NMR (CDCl3): d 25.2,
26.4, 34.1, 54.1, 63.8, 126.9, 127.5, 128.5, 144.9. GC–MS:
265, 188, 167. MS-ES(C): 266.2 (MC1). Anal. Calcd for
C19H23N: C, 85.99; H, 8.74; N, 5.28. Found: C, 84.20; H,
8.70; N, 5.31.
1
4.5.4. N-[(2-pyridinyl)methyl]cyclohexanamine (3d). H
NMR (CDCl3): d 1.02–1.93 (m, 11H), 2.46 (m, 1H), 3.84 (s,
2H), 7.27 (m, 2H), 8.54 (m, 2H). 13C NMR (CDCl3): d 25.1,
26.3, 33.7, 49.9, 56.4, 123.1, 150.0. GC–MS: 190, 147, 92.
MS-ES(C): 191.2 (MC1). Anal. Calcd for C12H18N2: C,
75.74; H, 9.53; N, 14.72. Found: C, 75.64; H, 9.52; N, 14.70.
1
4.5.12. N-benzhydrylcyclopropanamine (3m). H NMR
(CDCl3): d 0.38 (d, JZ5.1 Hz, 4H), 1.98 (br s, 1H), 2.07 (m,
1H), 4.91 (s, 1H), 7.12–7.36 (m, 10 H). 13C NMR (CDCl3):
d 6.8, 29.7, 67.3, 127.0, 127.5, 128.5, 144.3. GC–MS: 223,
222, 167, 152. MS-ES(C): 224.3 (MC1). Anal. Calcd for
C16H17N: C, 86.05; H, 7.67; N, 6.27. Found: C, 85.88; H,
7.72; N, 6.40.
1
4.5.5. N-benzylcyclohexanamine (3e). H NMR (CDCl3):
d 1.15–1.96 (m, 11H), 2.48–2.60 (m, 1H), 3.84 (s, 2H),
7.25–7.37 (m, 5H). 13C NMR (CDCl3): d 25.0, 26.0, 33.0,
50.6, 56.1, 127.1, 128.6, 139.6. GC-MS: 189, 146, 91. MS-
ES(C): 190.4 (MC1). Anal. Calcd for C13H19N: C, 82.48;
H, 10.12; N, 7.40. Found: C, 82.02; H, 10.09; N, 7.36.
1
4.5.13. 2-(Benzhydrylamino)acetonitrile (3n). H NMR
4.5.6. N-[(2-naphthyl)methyl]cyclohexanamine (3f). 1H
NMR (CDCl3): d 0.91–1.98 (m, 11H), 2.49–2.55 (m, 1H),
3.98 (s, 2H), 7.41–7.53 (m, 3H), 7.70–7.82 (m, 4H). 13C
NMR (CDCl3): d 25.2, 26.3, 33.8, 51.3, 56.3, 125.6, 126.1,
126.4, 126.7, 127.7, 127.8, 128.1, 132.7, 133.6, 138.7. GC–
MS: 239, 196, 141, 115, 98. MS-ES(C): 240.3 (MC1).
Anal. Calcd for C17H21N: C, 85.30; H, 8.84; N, 5.85. Found:
C, 84.98; H, 8.81; N, 5.83.
(CDCl3): d 1.95 (br s, 1H), 3.50 (s, 2H), 5.06 (s, 1H), 7.21–
7.44 (m, 10H). 13C NMR (CDCl3): d 35.4, 65.8, 117.7,
127.4, 127.8, 128.9, 141.9. GC–MS: 222, 167, 145, 104, 67.
MS-ES(C): 223.4 (MC1). Anal. Calcd for C15H14N2: C,
81.05; H, 6.35; N, 12.60. Found: C, 81.36; H, 6.52; N, 12.12.
4.5.14. 2-(Benzhydrylamino)acetic acid ethyl ester (3o).
1H NMR (CDCl3): d 1.24 (t, JZ7.2 Hz, 3H), 2.22 (m, 1H),
3.37 (s, 2H), 4.17 (q, JZ7.2 Hz, 2H), 4.88 (s, 1H), 7.18–
7.47 (m, 10H). 13C NMR (CDCl3): d 14.3, 49.2, 60.8, 66.7,
127.3, 127.5, 128.6, 143.4, 172.6. GC–MS: 182, 167, 118,
91. MS-ES(C): 270.2 (MC1). Anal. Calcd for C17H19NO2:
C, 75.81; H. 7.11; N, 5.20; O, 11.88. Found: C, 75.51; H,
7.33; N, 5.02.
4.5.7. N-[(2-quinolinyl)methyl]cyclohexanamine (3g). 1H
NMR (CDCl3): d 1.24–2.02 (m, 11H), 2.61 (m, 1H), 4.17 (s,
2H), 7.44–8.18 (m, 6H). 13C NMR (CDCl3): d 25.1, 26.2,
33.4, 52.8, 57.1, 120.7, 126.2, 127.5, 127.7, 129.1, 129.6,
136.6, 147.8, 160.2. GC–MS: 238, 195, 182, 157, 129, 77,
55. MS-ES(C): 241.3 (MC1). Anal. Calcd for C16H20N2:
C, 79.96; H, 8.39; N, 11.66. Found: C, 80.15; H, 8.39; N,
11.46.
4.5.15. 2-Cyclohexylamino-2-phenyl acetic acid ethyl
ester (3p). 1H NMR (CDCl3): d 1.08–1.84 (m, 13H),
2.03–2.04 (br s, 1H), 2.33–2.37 (m, 1H), 4.08–4.22 (m, 2H),
4.51 (s, 1H), 7.26–7.39 (m, 5H). 13C NMR (CDCl3): d 14.2,
25.0, 26.2, 33.4, 33.6, 54.6, 61.2, 62.5, 127.4, 128.0, 128.8,
138.9, 173.8. GC–MS: 260, 188, 106, 79. MS-ES(C): 262.1
(MC1). Anal. Calcd for C16H23NO2: C, 73.53; H, 8.87; N,
5.36; O, 12.24. Found: C, 73.23; H, 8.69; N, 5.47.
1
4.5.8. N-(1-phenylethyl)cyclohexanamine (3h). H NMR
(CDCl3): d 1.33 (d, JZ7.0 Hz, 3H), 1.01–1.72 (m, 11H),
2.26 (m, 1H), 3.96 (q, JZ7.0 Hz, 1H), 7.16–7.34 (m, 5H).
13C NMR (CDCl3): d 14.2, 25.1, 25.4, 26.3, 33.3, 34.6, 53.8,
54.6, 126.5, 128.5, 146.4. GC–MS: 203, 188, 160, 105, 77,
56. MS-ES(C): 204.3 (MC1). Anal. Calcd for C14H21N: C,
82.70; H, 10.41; N, 6.89. Found: C, 82.34; H, 10.43; N, 6.87.
4.5.16. 2-Phenyl-(10-phenylethylamino)acetic acid ethyl
ester [(S,R)-3q and (R,R)-3q]. The two diastereomers 3q
were separated by simple column chromatography (silica
gel, hexane/AcOEt 9:1). Major product: (S,R)-3q. 1H NMR
(CDCl3): d 1.13 (t, JZ7.2 Hz, 3H), 1.34 (d, JZ6.6 Hz, 3H),
2.30–2.50 (br s, 1H), 3.56 (q, JZ6.6 Hz, 1H), 4.00–4.13 (m,
2H), 4.17 (s, 1H), 7.22–7.38 (m, 10H). 13C NMR (CDCl3): d
14.1, 24.5, 54.8, 61.2, 62.8, 127.1, 127.3, 127.8, 128.1,
128.6, 128.7, 138.6, 144.8, 173.0. [a]2D5 (c 0.50, MeOH)
C130.6. GC–MS: 283, 210, 105, 79. MS-ES(C): 284.3
(MC1). Anal. Calcd for C19H23NO2: C, 76.73; H, 7.80; N,
4.71; O, 10.76. Found: C, 76.13; H, 7.96; N, 4.60. Minor
product: (R,R)-3q. 1H NMR (CDCl3): d 1.22 (t, JZ7.2 Hz,
3H), 1.39 (d, JZ6.6 Hz, 3H), 2.25–2.40 (br s, 1H), 3.56 (q,
JZ6.6 Hz, 1H), 4.11–4.26 (m, 3H), 7.23–7.35 (m, 10H).
13C NMR (CDCl3): d 14.3, 24.9, 56.7, 61.2, 63.1, 127.1,
127.2, 127.3, 128.0, 128.6, 128.7, 128.8, 138.7, 145.0,
173.9. [a]2D5 (c 0.49, MeOH) ZK19.5. GC–MS: 283, 210,
105, 79. MS-ES(C): 284.3 (MC1). Anal. Calcd for
C19H23NO2: C, 76.73; H, 7.80; N, 4.71; O, 10.76. Found:
C, 76.24; H, 8.06; N, 4.52.
1
4.5.9. N-[1-(20-naphthyl)ethyl]cyclohexanamine (3i). H
NMR (CDCl3): d 1.01–1.12 (m, 5H), 1.40 (d, JZ6.6 Hz,
3H), 1.53–1.72 (m, 5H), 2.03 (m, 1H), 2.30 (m, 1H), 4.13 (q,
JZ6.6 Hz, 1H), 7.41–7.47 (m, 3H), 7.71 (s, 1H), 7.74–7.83
(m, 3H). 13C NMR (CDCl3): d 25.2, 26.3, 33.4, 34.8, 53.9,
54.8, 125.0, 125.2, 125.5, 126.0, 127.8, 127.9, 128.3, 132.9,
133.6, 144.0. GC–MS: 254, 238, 155, 98, 56, 41. MS-ES(C
): 254.4 (MC1). Anal. Calcd for C18H23N: C, 85.32; H,
9.15; N, 5.53. Found: C, 84.92; H, 9.11; N, 5.50.
4.5.10. N-[1-(20-pyridinyl)ethyl]cyclohexanamine (3j). 1H
NMR (CDCl3): d 1.02–1.98 (m, 11H), 1.36 (d, JZ6.6 Hz,
3H), 2.23 (m, 1H), 4.03 (q, JZ6.6 Hz, 1H), 7.12–7.16 (m,
1H), 7.27–7.31 (m, 1H), 7.61–7.66 (m, 1H), 8.54–8.57 (m,
1H). 13C NMR (CDCl3): d 23.6, 25.1, 25.3, 26.3, 33.4, 34.5,
54.3, 55.9, 121.3, 121.9, 136.5, 149.4, 165.5. GC–MS: 203,
189, 161, 107, 97. MS-ES(C): 205.3 (MC1). Anal. Calcd
for C13H20N2: C, 76.42; H, 9.87; N, 13.71. Found: C, 76.81;
H, 9.68; N, 13.51.